Bumetanide Injection
Sagent Pharmaceuticals
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 01/31/2018
- Change date
- 09/30/2026
- Package NDC
- 25021-321-04
- Generic name
- Bumetanide Injection
- Contact info
- 866-625-1618
- Resolved note
- Available
- Update date
- 09/30/2026
- Dosage form
- Injection
- Presentation
- Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-04)
- Company name
- Sagent Pharmaceuticals
- Status
- Resolved
- Therapeutic category
- Cardiovascular
- Harmonized identifiers (openFDA)
- Application number
- ANDA074441
- Brand name
- BUMETANIDE
- Generic name
- BUMETANIDE
- Manufacturer name
- Sagent Pharmaceuticals
- Product NDC
- 25021-321
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Substance name
- BUMETANIDE
- RxCUI
- 282486, 1727569
- SPL ID
- 88a191ea-bf0d-4c27-a33c-91a126ff1aba
- SPL set ID
- c38a404d-a919-4a2c-9fbb-d0655dee9516
- Package NDC
- 25021-321-04, 25021-321-10
- Nui
- N0000175366, N0000175590
- Pharm class pe
- Increased Diuresis at Loop of Henle [PE]
- Pharm class epc
- Loop Diuretic [EPC]
- UNII
- 0Y2S3XUQ5H
